Investors are having second thoughts about the market's biggest tech names, with the Magnificent Seven down an average of about 2.8% over the past three months.

Over that period, dividend payers-especially dividend aristocrats Medtronic, McCormick and T. Rowe Price-have been attracting new attention.

The ProShares S&P 500 Dividend Aristocrats ETF has returned 8.4% in the past three months. It's a big change, because the fund's blue-chip stocks have had trouble keeping up with the torrid pace of the market's technology darlings over the past few years. Dividend aristocrats are companies that have made and paid dividends for 25 straight years,

"It's fair to say that NOBL outperformance is simply overdue," says ProShares investment strategist Simeon Hyman, referring to the ETF's ticker. He notes the fund's holdings are equally weighted, a strategy that has thrived as market returns broaden. He also points to strong second-quarter earnings.

"NOBL's constituents grew their earnings by nearly 33% year-over-year, a dramatic increase over a roughly 5% increase in the first quarter," he says.

What individual dividend aristocrats look potentially appealing to income-focused investors? To find out we used FactSet to screen the fund's holdings. We looked for stocks that outperformed the S&P 500 over the past three months and boast dividend yields of at least 3%.

To make sure our list didn't include any potential yield traps, we also looked for stocks that Wall Street expects to grow earnings in both 2026 and 2027 and which payout no more than 80% of their net income in dividends.

Our list includes six names: medical device company Medtronic, with a 3.2% dividend yield; spice maker McCormick, yielding 3.5%; mutual fund manager T. Rowe Price, 4.7%; drinks company Brown-Forman, owner of Jack Daniel's, 3.5%; utility Consolidated Edison, 3.3%; and consumer goods giant Procter & Gamble, 3.0%.

Medtronic has rallied the most in the past three months, gaining more than 23%. Shares were up again on Tuesday, gaining about 1%, after the company reported better-than-expected earnings and revenue and improved its full-year outlook, helped by growing sales at its cardiovascular and neuroscience arms. The company also announced a $700 million deal to distribute Cornerstone Robotics' "Sentire" surgical system outside the U.S.

McCormick has also rallied, climbing more than 15% in the past three months. It's been a tough market for packaged food companies, although McCormick, which focuses on spices, seasonings and condiments, has been able to avoid GLP-1 fears that have plagued snack makers and processed food makers.

Still, the company made a huge bet earlier this year when it agreed to merge with Unilver's food business, which will bring it brands such as Hellmann's mayonnaise and Knorr spice mixes. While the deal makes strategic sense, Wall Street analysts warned of major execution risks after it was announced this spring.

Despite the recent rally, the stock remains down about 20% on the year. However, that means it should have much farther to run if management can pull of the Unilver deal, which would more than double McCormick's annual revenue.

T. Rowe Price, long known for its stock-picking prowess, has struggled to adapt to an investment landscape dominated by income and ETFs. But it has expanded into growth areas including private assets and cryptocurrency and managed to grow assets under management last quarter, thanks to rising stock prices. Shares have gained nearly 9% in the past three months.

Brown-Forman has struggled, along with other drinks companies, with declining alcohol consumption. The company's CEO announced his plan to retire after a successor is found in July. Still, Wall Street analysts expect the company to report earnings growth of 2.6% for the fiscal first quarter, which the company will report Wednesday. Full-year earnings growth, for the fiscal year that ends in April 2027, is expected to top 10%.

New York-based ConEd operates in a difficult political environment, considering both President Donald Trump and New York City Mayor Zohran Mamdani have recently called for lower electricity rates. Still, Wall Street forecasts call for steady earnings-per-share growth of 6% to 7% in 2026 and 2027, according to FactSet.

Consumer products giant Procter & Gamble posted better-than-expected fiscal fourth-quarter earnings in July. The company, which has faced higher materials and energy costs, is expected to see profit growth accelerate from 1% in the current fiscal year to 6% in fiscal 2028.